<?xml version="1.0" encoding="UTF-8"?>
<p>Since December 2019, countries have quickly shifted from spectators to victims of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak. The coronavirus disease 2019 (COVID-19) pandemic has overwhelmed healthcare systems and crippled economies around the world, including the United States. Unlike China, many countries had time to prepare for their epidemics and, as of March 25, remain in the early stages. Time has allowed the scientific community to bear arms and mount expedited research efforts in unforeseen fashion. The collaboration between academic institutions and government agencies is unprecedented and inspiring. Countless hours and sleepless nights from academics around the world have resulted in a united front to mitigate morbidity and mortality from COVID-19. Despite these concerted efforts, another pandemic, in its own right, threatens to destroy the meticulously built scientific juggernaut surrounding COVID-19. Those are alternative facts. This commentary uses a recent study of hydroxychloroquine to demonstrate the dire need for randomized clinical trials, but more importantly, to explore the potential consequences of misinformation, how fear fuels its impact, and offer guidance to maintain scientific integrity without relinquishing hope.</p>
